The immune-related adverse events paradox in locally advanced or metastatic urothelial cancer patients receiving atezolizumab: Analysis of individual participant data from IMvigor210 and IMvigor211

Saved in:
Bibliographic Details
Published in:European urology 2023-02, Vol.83, p.S763-S764
Main Authors: Robesti, D., Nocera, L., Belladelli, F., Schultz, J.G., Fallara, G., Marandino, L., Raggi, D., Montorsi, F., Necchi, A., Martini, A.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0302-2838
DOI:10.1016/S0302-2838(23)00581-X